Prof Kelly Chibale discusses the importance of optimised dosing for African populations

22 Jan 2021 - 07:15


Prof Kelly Chibale is passionate about improving the treatment outcomes of African patients. Read more about why and how H3D is interested in understanding drug metabolism in the African population.

"African patient responses to the medicines are varied and accompanied by suboptimal treatment outcomes in some instances” 


Read the full article published in Health Policy Watch here